Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ChapStick Active Performance is a topical lip balm product designed for moisturizing and sun protection, featuring **zinc oxide 20.5%** as the active ingredient functioning as a physical sunscreen to block UVA and UVB rays. It includes a blend of emollients and skin conditioners such as aloe barbadensis leaf extract, argania spinosa kernel oil, astrocaryum murumuru seed butter, beeswax, butyrospermum parkii butter, and tocopherol for hydration and antioxidant benefits, applied to prevent chapped lips and sunburn on lips during outdoor activities. Marketed as a 2-in-1 lip moisturizer, it is available in varieties like unscented, fresh mint, and wild berry, and is produced by GlaxoSmithKline under the ChapStick brand.[1][3][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ChapStick Active Performance.